Improving cervical cancer screening and care for women with HIV in Kenya
ENHANcing CErvical cancer screening and treatment in women LIviNg with HIV in KenyA (ENHANCE LINKAge)
This project tries new ways to make cervical cancer screening and follow-up care easier and more reliable for women living with HIV in Kenya.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11175527 on NIH RePORTER |
What this research studies
If you are a woman living with HIV in Kenya, this project focuses on making cervical cancer screening part of routine HIV clinic care. The team will work in public HIV clinics to identify and fix patient, provider, and system problems that stop women from getting follow-up testing and treatment. They will pilot practical strategies to link women who need further diagnostic tests or treatment with accessible services and will track those services for quality and accountability. The work uses implementation science methods to find approaches that clinics can continue using after the project ends.
Who could benefit from this research
Good fit: Women living with HIV who receive care at participating public HIV clinics in Kenya and are eligible for cervical cancer screening are the ideal candidates.
Not a fit: Women without HIV, those who do not attend participating clinics, or those who cannot access follow-up services may not directly benefit from this project.
Why it matters
Potential benefit: If successful, more women with HIV could get timely diagnosis and treatment for cervical precancers, lowering the chance of developing cervical cancer.
How similar studies have performed: Past integration efforts supported by programs like PEPFAR have broadened screening but often failed to ensure follow-up care, so this project builds on that experience to improve linkage and treatment.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.